Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
e-Letters: Observations

The Impact of Gram-Negative Bacilli in Bacteremic Skin and Soft Tissue Infections Among Patients With Diabetes

  1. Eva Benavent1,
  2. Oscar Murillo1⇑,
  3. Imma Grau1,
  4. Julia Laporte-Amargos2,
  5. Joan Gomez-Junyent1,
  6. Laura Soldevila1,
  7. Fe Tubau3,4,
  8. Javier Ariza1 and
  9. Roman Pallares1
  1. 1Department of Infectious Diseases, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Universidad de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
  2. 2Department of Infectious Diseases, Hospital Universitari de Bellvitge, Universidad de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
  3. 3Department of Microbiology, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), Universidad de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
  4. 4Respiratory Diseases Networking Biomedical Research Centre (CIBERes), Instituto de Salud Carlos III, Madrid, Spain
  1. Corresponding author: Oscar Murillo, omurillo{at}bellvitgehospital.cat
Diabetes Care 2019 Jul; 42(7): e110-e112. https://doi.org/10.2337/dc18-2294
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Skin and soft tissue infections (SSTIs) are common and may be more severe in patients with diabetes. In particular, the development of diabetic foot ulcers facilitates diabetic foot infections (DFIs), which are generally not included in SSTI classifications (1). In these situations, gram-negative bacilli (GNB) may have an impact on the etiology of severe SSTIs.

We aimed to analyze the GNB etiology, epidemiologic trends, and risk factors for mortality among a large cohort of adult patients with diabetes attended in our hospital (1996–2016) with bloodstream infections from an SSTI source (1). Cases with nosocomial acquisition or due to a sacral decubitus ulcer were excluded.

Out of 30,363 episodes of bacteremia, 7,202 (23.7%) occurred in patients with diabetes; this proportion increased over time from 17.7% in 1996–2000 to 28.3% in 2011–2016 (P < 0.001). Among bacteremic episodes in patients with diabetes, 247 (3.4%) were secondary to SSTIs, of which 223 were analyzed (Table 1). The most common clinical form was cellulitis (n = 184, 82.5%). DFIs represented 25% of cases (with abscesses in 23%), of which 41.8% required surgery (amputation, 43.5%).

View this table:
  • View inline
  • View popup
Table 1

Clinical characteristics of the studied cohort and differences between patients with an infection due to GNB, GPC, or mixed polymicrobial infection

Regarding the microbiology, 138 (61.9%) cases were caused exclusively by gram-positive cocci (GPC) (mainly Streptococcus spp. [63.8%] and Staphylococcus aureus [29%]) and 68 (30.5%) by GNB (Escherichia coli [26.5%] and Pseudomonas spp. [26.5%]). Seventeen cases (7.6%) were polymicrobial mixed infections (combining GPC and GNB); those were excluded for specific comparison of patients with GNB SSTIs vs. GPC SSTIs (Table 1). The former were older, had higher rates of diabetic complications and health care–related infections, had received prior antibiotics more often, and had infections that were mostly located on the lower extremities.

Comparison of the 1996–2000 and 2011–2016 time periods revealed an upward trend in the prevalence of GNB SSTIs (14.3% vs. 40.6%; P = 0.020), in the previous use of antibiotics (14.3% vs. 44.9%; P = 0.003), and in the proportion of GNB resistant to frequently used antibiotics (amoxicillin-clavulanate and fluoroquinolones) (0% vs. 20.3%; P = 0.100).

The 30-day mortality rate was 21.5%, ranging from 57.9% in necrotizing fasciitis to 17.2%, 14.3%, and 10.5% in cellulitis, pyomyositis, and abscesses, respectively (P < 0.001). Mortality from DFIs was 16%. Patients with GNB SSTIs had higher mortality rates (32.4%) compared with patients with GPC SSTIs (13.8%) (P = 0.002) in all types of SSTIs but necrotizing fasciitis, which had an intrinsic high mortality independent of the etiology. In multivariate analysis after adjusting for age, sex, presence of coronary disease, type of SSTI (excluding necrotizing fasciitis), and site of acquisition, infection due to GNB was the only statistically significant risk factor for mortality (adjusted odds ratio 2.73 [95% CI 1.11–6.70]; P = 0.028).

Our study shows an increasing trend in GNB SSTIs among patients with diabetes, with consequent greater mortality. The results may be inherently limited by the retrospective review and conditioned not only by diabetes but also by other comorbidities of the patients or the presence of bacteremia itself.

The most common SSTI was cellulitis, but DFIs represented 25% and had higher rates of abscesses and need for amputation. This supports the previous opinion about considering DFIs in further classifications of SSTIs because of their frequency and particular characteristics (1).

Despite the dominance of GPC etiology, we observed a greater proportion of GNB (30.5%) than is classically reported (2). This fact seems not only related to the presence of ulcers but also the location of SSTIs on the lower extremities and the specific immunosuppressive conditions that patients with diabetes may present. Also, we recognized a significant increase in the proportion of GNB bacteremia over time, as has been noted worldwide in similar settings (3). Finally, we noticed an increase in the SSTIs caused by GNB resistant to the most commonly used antibiotics but without a specific increment in those GNB defined as multidrug resistant, thus leading us only to hypothesize about their lower virulence or a possible emergence of multidrug resistance in the future.

In our study, the mortality rates varied according to the type of SSTI and were high considering overall mortality from SSTIs but comparable to other studies with the same type of patients or with bloodstream infections (4). Notably, infections due to GNB were associated with twofold increased odds of mortality, after adjusting for other causes. These differences were detected in all types of SSTIs except necrotizing fasciitis. To our knowledge, scarce reference has been made previously to GNB etiology as an independent risk factor for mortality in SSTIs (5).

In conclusion, because of the increase in GNB infections, including those resistant to the most commonly used antibiotics, and their greater mortality, appropriate empirical coverage is mandatory, whether in patients with SSTIs and severe systemic manifestations or suspicion of bacteremia.

Article Information

Acknowledgments. The authors thank John B. Warren (International House Barcelona) for revising the English manuscript.

Funding. E.B. was supported by a grant from the Spanish Ministerio de Educación, Cultura y Deporte (FI 16/00397).

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. E.B. researched data, performed the analysis of the data, and wrote the manuscript. O.M., I.G., J.A., and R.P. contributed to discussion and reviewed and edited the manuscript. J.G.-J. contributed to the statistical analysis and discussion. J.L.-A., L.S., and F.T. researched data. E.B. and O.M. are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Prior Presentation. The preliminary results of this study were reported in part at the 28th European Congress of Clinical Microbiology and Infectious Diseases, Madrid, Spain, 21–24 April 2018.

  • Received November 2, 2018.
  • Accepted April 18, 2019.
  • © 2019 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Lipsky BA,
    2. Silverman MH,
    3. Joseph WS
    . A proposed new classification of skin and soft tissue infections modeled on the subset of diabetic foot infection. Open Forum Infect Dis 2016;4:ofw255
    OpenUrl
  2. ↵
    1. Gunderson CG,
    2. Martinello RA
    . A systematic review of bacteremias in cellulitis and erysipelas. J Infect 2012;64:148–155
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Ho J,
    2. Tambyah PA,
    3. Paterson DL
    . Multiresistant gram-negative infections: a global perspective. Curr Opin Infect Dis 2010;23:546–553
    OpenUrlCrossRefPubMed
  4. ↵
    1. Marwick C,
    2. Broomhall J,
    3. McCowan C, et al
    . Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. J Antimicrob Chemother 2011;66:387–397
    OpenUrlCrossRefPubMed
  5. ↵
    1. Lipsky BA,
    2. Tabak YP,
    3. Johannes RS,
    4. Vo L,
    5. Hyde L,
    6. Weigelt JA
    . Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 2010;53:914–923
    OpenUrlCrossRefPubMed
    1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
    . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864–874
    OpenUrlCrossRefPubMedWeb of Science
    1. Friedman ND,
    2. Kaye KS,
    3. Stout JE, et al
    . Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2001;137:791–797
    OpenUrl
PreviousNext
Back to top
Diabetes Care: 42 (7)

In this Issue

July 2019, 42(7)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Impact of Gram-Negative Bacilli in Bacteremic Skin and Soft Tissue Infections Among Patients With Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Impact of Gram-Negative Bacilli in Bacteremic Skin and Soft Tissue Infections Among Patients With Diabetes
Eva Benavent, Oscar Murillo, Imma Grau, Julia Laporte-Amargos, Joan Gomez-Junyent, Laura Soldevila, Fe Tubau, Javier Ariza, Roman Pallares
Diabetes Care Jul 2019, 42 (7) e110-e112; DOI: 10.2337/dc18-2294

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

The Impact of Gram-Negative Bacilli in Bacteremic Skin and Soft Tissue Infections Among Patients With Diabetes
Eva Benavent, Oscar Murillo, Imma Grau, Julia Laporte-Amargos, Joan Gomez-Junyent, Laura Soldevila, Fe Tubau, Javier Ariza, Roman Pallares
Diabetes Care Jul 2019, 42 (7) e110-e112; DOI: 10.2337/dc18-2294
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes
  • Changes in Cardiovascular Biomarkers Associated With the Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes
  • Citizenship Status and Prevalence of Diagnosed and Undiagnosed Hypertension and Diabetes Among Adults in the U.S., 2011–2016
Show more e-Letters: Observations

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.